Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chaumette

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
L'Encephale|May 30, 2017
[Switching from antipsychotics to aripiprazole and risk of agitation]B Chaumette, M Masson, M Barde, et al.
L'Encephale|August 17, 2014
[Epigenetics of schizophrenia: a review]F Rivollier, L Lotersztajn, B Chaumette, et al.
L'Encephale|June 24, 2020
[Management of cardiovascular co-morbidities in young patients with early onset psychosis: State of the art and therapeutic perspectives]A Frajerman, V Morin, B Chaumette, et al.
L'Encephale|March 11, 2020
[Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?]A Frajerman, O Kebir, B Chaumette, et al.
L'Encephale|May 11, 2016
[Stress and psychotic transition: A literature review]B Chaumette, O Kebir, C Mam Lam Fook, et al.
Molecular Psychiatry|April 27, 2016
Methylomic changes during conversion to psychosisO Kebir, B Chaumette, F Rivollier, et al.
Psychiatry Research|October 2, 2025
Effects of DISC1 and hypoxia-sensitive genes on dermatoglyphics and cognitive function in schizophreniaA Sotero-Moreno, M Guardiola-Ripoll, N Hostalet, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
L'Encephale|May 30, 2017
[Switching from antipsychotics to aripiprazole and risk of agitation]B Chaumette, M Masson, M Barde, et al.
L'Encephale|August 17, 2014
[Epigenetics of schizophrenia: a review]F Rivollier, L Lotersztajn, B Chaumette, et al.
L'Encephale|June 24, 2020
[Management of cardiovascular co-morbidities in young patients with early onset psychosis: State of the art and therapeutic perspectives]A Frajerman, V Morin, B Chaumette, et al.
L'Encephale|March 11, 2020
[Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?]A Frajerman, O Kebir, B Chaumette, et al.
L'Encephale|May 11, 2016
[Stress and psychotic transition: A literature review]B Chaumette, O Kebir, C Mam Lam Fook, et al.
Molecular Psychiatry|April 27, 2016
Methylomic changes during conversion to psychosisO Kebir, B Chaumette, F Rivollier, et al.
Psychiatry Research|October 2, 2025
Effects of DISC1 and hypoxia-sensitive genes on dermatoglyphics and cognitive function in schizophreniaA Sotero-Moreno, M Guardiola-Ripoll, N Hostalet, et al.
Pageof 1